AU Patent

AU2016325619A1 — Methods and intermediates for the preparation bile acid derivatives

Assigned to Intercept Pharmaceuticals Inc · Expires 2018-04-12 · 8y expired

What this patent protects

The present invention relates to methods and novel intermediates useful in the preparation of a compound or a pharmaceutically acceptable salt thereof. An objective of the present invention is to provide methods of preparing bile acid derivatives and novel intermediates. A use of…

USPTO Abstract

The present invention relates to methods and novel intermediates useful in the preparation of a compound or a pharmaceutically acceptable salt thereof. An objective of the present invention is to provide methods of preparing bile acid derivatives and novel intermediates. A use of the methods and intermediates described relates to the synthesis of bile acid derivatives which activate both FXR and TGR5.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016325619A1
Jurisdiction
AU
Classification
—
Expires
2018-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.